General - Press Releases

Date	Title	Company
11-Jan-2022	Takeda übernimmt Adaptate Biotherapeutics zur Entwicklung neuartiger Gamma-delta-(γδ)-T-Zell-Engager-Therapien gegen solide Tumore	Businesswire
11-Jan-2022	Samenvatting: Toezichthouders keuren Impella 5.5 met SmartAssist goed in Japan en Hongkong; US FDA verleent voorwaardelijke IDE-goedkeuring voor Impella BTR voor eerste-humanstudie naar vroege haalbaarheid	Businesswire
11-Jan-2022	Riassunto: Approvata a livello normativo Impella 5.5 con SmartAssist in Giappone e a Hong Kong; la FDA statunitense concede a Impella BTR l'approvazione condizionale IDE per il primo studio di fattibilità precoce su soggetti umani	Businesswire
10-Jan-2022	Riassunto: Takeda rileverà Adaptate Biotherapeutics per sviluppare nuove terapie basate su T-cell engager Gamma Delta (γδ) mirate ai tumori solidi	Businesswire
10-Jan-2022	ZIVO Bioscience Names Chairman John B. Payne as President and CEO	Businesswire
10-Jan-2022	Labcorp to Announce Fourth Quarter and Full Year 2021 Financial Results on February 10, 2022	Businesswire
10-Jan-2022	Takeda Emphasizes Strategy for Delivering Sustainable Growth Over Next Decade at the 40th Annual J.P. Morgan Healthcare Conference	Businesswire
10-Jan-2022	Nashville Biosciences and Illumina Announce Agreement to Establish Preeminent Clinico-Genomic Resource for Life Sciences Research & Development	Businesswire
10-Jan-2022	Takeda en passe d'acquérir Adaptate Biotherapeutics pour développer de nouvelles thérapies associées aux engageurs de cellules T Gamma Delta (γδ) ciblant les tumeurs solides	Businesswire
10-Jan-2022	Fish & Richardson Expands Life Sciences Group with Addition of Principal Dr. Helen Baca	Businesswire
10-Jan-2022	Takeda adquiere Adaptate Biotherapeutics para desarrollar nuevas terapias de activación de células T gamma delta (γδ) dirigidas a tumores sólidos	Businesswire
10-Jan-2022	Takeda vai adquirir a Adaptate Biotherapeutics para desenvolver novas terapias engagers de células T γδ (gama delta) destinadas a tumores sólidos	Businesswire
10-Jan-2022	2021 Cardiac Rhythm Management Devices Medical Devices Pipeline Product Landscape Report - ResearchAndMarkets.com	Businesswire
10-Jan-2022	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Bright Health Group, Inc. (BHG) on Behalf of Investors	Businesswire
10-Jan-2022	TheraVet Announces the Initiation of Coverage of Its Stock by Degroof Petercam	Businesswire
10-Jan-2022	Pherecydes Pharma Announces its Financial Agenda for 2022	Businesswire
10-Jan-2022	Global Specialty Pharmaceutical Partnering Terms and Agreements Analysis Report 2014-2021 - ResearchAndMarkets.com	Businesswire
10-Jan-2022	Vivacitas Oncology to Present AR-67 at the Biotech Showcase Investor Conference	Newswire
10-Jan-2022	Biocom California Selects New Chair for its Board of Directors	Businesswire
10-Jan-2022	Immune-Onc Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference	Businesswire